Cigna Group Files 8-K with Material Agreements and Officer Changes

Ticker: CI · Form: 8-K · Filed: 2025-04-28T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, officer-changes, financial-obligation

TL;DR

Cigna Group 8-K: New deals, old deals gone, exec changes, shareholder votes. Big moves happening.

AI Summary

On April 22, 2025, The Cigna Group entered into a material definitive agreement and also terminated a material definitive agreement. The company also created a direct financial obligation or an obligation under an off-balance sheet arrangement. Additionally, there were changes in directors or officers, including the appointment of certain officers and compensatory arrangements for certain officers, and matters were submitted to a vote of security holders.

Why It Matters

This 8-K filing indicates significant corporate actions, including new agreements, potential financial obligations, and changes in leadership, which could impact the company's strategic direction and financial health.

Risk Assessment

Risk Level: medium — The filing details material definitive agreements, terminations, and financial obligations, which inherently carry business and financial risks.

Key Players & Entities

FAQ

What was the nature of the material definitive agreement entered into by The Cigna Group on April 22, 2025?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

What was the reason for the termination of a material definitive agreement by The Cigna Group?

The filing states that a material definitive agreement was terminated, but the specific reasons for this termination are not detailed in the provided text.

What type of direct financial obligation or off-balance sheet arrangement was created by The Cigna Group?

The filing confirms the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not elaborated in the provided text.

Were there any changes in the board of directors or executive officers of The Cigna Group?

Yes, the filing reports the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers.

Were any matters submitted to a vote of security holders by The Cigna Group?

Yes, the filing indicates that matters were submitted to a vote of security holders.

From the Filing

0001140361-25-016027.txt : 20250428 0001140361-25-016027.hdr.sgml : 20250428 20250428161542 ACCESSION NUMBER: 0001140361-25-016027 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250422 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250428 DATE AS OF CHANGE: 20250428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 25880566 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 ef20048062_8k.htm 8-K false 0001739940 NYSE 0001739940 2025-04-22 2025-04-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2025 The Cigna Group (Exact name of registrant as specified in its charter) Delaware 001-38769 82-4991898 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 900 Cottage Grove Road Bloomfield , Connecticut 06002 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 860 ) 226-6000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On April 24, 2025, The Cigna Group (the “Company”) entered into a $6.5 billion Revolving Credit and Letter of Credit Agreement with the banks named therein, JPMorgan Chase Bank, N.A., as administrative agent, and BofA Securities, Inc., Citibank, N.A., Morgan Stanley Senior Funding, Inc. and Wells Fargo Securities, LLC, as joint lead arrangers and

View on Read The Filing